Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
PROJECT ABSTRACT
Methylglyoxal (MG) is a potent intracellular glycating agent that forms advanced glycation endproducts. Formed
spontaneously from 3-carbon glycolytic intermediates, MG rapidly glycates proteins and nucleotides, damages
mitochondria and directly increases reactive oxygen species production; thus inducing a pro-oxidant state and
senescent-like condition. MG and the related glyoxalase enzymatic defense system are emerging as critical
players in aging and age-related disease processes. Under physiologic conditions MG is rapidly detoxified by
glyoxalase 1 (GLO1). However, when GLO1 is attenuated, MG flux is increased and MG-modified proteins
accumulate (termed dicarbonyl stress), both within and outside the cell. Dicarbonyl stress promotes glucose
intolerance, oxidative stress and inflammation. The mechanisms regulating GLO1 protein stability and enzymatic
activity in skeletal muscle tissue, a tissue critical to glucose metabolism, are not well studied and there is a critical
need to understand the functional consequences of reduced GLO1 in the context of obesity, aging and age-
related disease. GLO1 is critical to cellular function and subject to numerous posttranslational modifications
(PTMs) that regulate GLO1 protein stability and activity. Our objective is to establish robust translational models
to delineate the mechanisms by which GLO1 is regulated to better understand the functional consequences of
attenuated GLO1. The generation of new, state-of-the-art translational models will help to accelerate the
understanding of GLO1 attenuation and dicarbonyl stress and the implications for skeletal muscle health across
both the life-span and health-span. We aim to establish the functional relevance of both GLO1 loss and the
impact of PTMs of GLO1 in human myotubes. Our approach is to attenuate GLO1 and mutate critical amino acid
residues using CRISPR gene editing technology, coupled with measures of dicarbonyl stress. We expect to
identify a novel, muscle specific mechanism of GLO1 dysregulation and methylglyoxal-mediated damage. The
successful completion of this work will have an important positive impact on advancing the understanding, and
provide potential therapeutic targets, to maintain skeletal muscle function with aging and age-related disease.
Public Health Relevance Statement
PROJECT NARRATIVE
Skeletal muscle is a critical organ towards whole body metabolic regulation. We have identified novel
mechanisms by which cellular metabolism maintains the abundance of critical antioxidant defense enzymes in
skeletal muscle. This proposal will explore the regulation of these critical cell proteins in skeletal muscle tissues
and the applicability of our finding in age-related diseases.
No Sub Projects information available for 1R21AG081916-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21AG081916-01
Patents
No Patents information available for 1R21AG081916-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21AG081916-01
Clinical Studies
No Clinical Studies information available for 1R21AG081916-01
News and More
Related News Releases
No news release information available for 1R21AG081916-01
History
No Historical information available for 1R21AG081916-01
Similar Projects
No Similar Projects information available for 1R21AG081916-01